Posted on

BAT invests a billion dollars in Romanian HnB factory

HnB Factory

There’s been a lot of talk recently from opponents of Heat not Burn – including, regrettably, some of the less intelligent vape reviewers – about how the technology has already peaked. Growth has slowed, they say; fewer smokers are switching to HnB, and the market is already saturated. It’s true that iQOS sales in Japan have slowed over the last quarter, but does this mean the great heated tobacco experiment is fizzling out?

Well, I’m not convinced. Has iQOS reached market saturation in Japan? It might have done. That wouldn’t really be a huge surprise. After all, iQOS is the first generation of HnB that’s really gone mass market. Maybe all the Japanese smokers who feel like switching have done so already, and sales are going to fall back to existing users replacing their devices. This happens when a new product disrupts an existing market.

What’s the good news?

Japan isn’t the only market for HnB, though – not by a long way. iQOS, the most widely available product, is now on sale in most of Europe as well as in Asia, but it hasn’t hit the huge US market yet. It’s still going through FDA approval, but if it gets there (and it probably will) millions more smokers are likely to switch. Then there’s Glo, which so far is only available in selected countries. Maybe KT&G will release their Lil outside South Korea – and I hope they do, because I have one on my desk right now and it’s excellent.

Then, of course, there’s the technology itself to consider. HnB has been around since the 1990s at least, but iQOS, Glo and Lil are the first generation of really effective devices. Compare that with e-cigarettes for a moment. The first really effective, widely available e-cig was probably the JoyeTech eGo. Now compare an eGo with today’s entry-level devices. There’s a bit of a difference, isn’t there? Well, iQOS and Glo are the eGo of heated tobacco.

Philip Morris, British American Tobacco, Japan Tobacco International and others are all working to improve and refine the technology that’s gone into their existing HnB systems. Over the next few years we can expect to see improved versions appearing – devices that will be even easier to use, come even closer to the experience of smoking a cigarette, and reduce the harm even more. A lot of smokers who weren’t quite convinced by the first generation of products will decide to switch once something even better is on the market.

Again, this is exactly what we saw with vaping. I found my first e-cig on a market stall in Kabul. It was an old-style three piece cigalike, and it was bloody awful. There was no way a device like that was going to replace my smoking habit, which seeing as 200 Marlboro cost a whole $10 in the PX was pretty heavy. On the other hand it did work just fine to keep nicotine deprivation at bay on my regular seven-hour flights home, so it was enough to keep e-cigs in my mind. Later, when I decided I really had to quit smoking, I found an eGo-C kit and that was actually good enough to do the job. What I’m using now, of course, blows an eGo – or a Marlboro, for that matter – right out of the water.

Growth to come

Anyway, I don’t think the market for Heat not Burn products has peaked, or even come close to its full potential. And, it seems, neither do British American Tobacco. I can say that pretty confidently, because BAT have just announced that they plan to spend a billion dollars upgrading one of their factories and turning it into their European centre for HnB manufacturing.

Romania was the first European market for Glo – and also an early one for iQOS – and BAT already have an established manufacturing capability there. The company’s market share in Romania is around 55%, and to support that they have a large factory at Ploiești. This is the factory that’s going to benefit from that billion-dollar investment over the next five years.

BAT’s plan is to roll Glo out across more European countries in the second half of this year, and to do that they need a reliable supply of Neostiks – ideally a supply that doesn’t involve shipping them from Asia. The plan is for Ploiești to become the sole European manufacturing and supply centre for Neostiks. The plant already supplies the European market with pods for the iFuse hybrid device, so it looks set to become a major centre for BAT’s reduced-harm products.

A bright future

If BAT weren’t anticipating strong sales of Glo in Europe, they’d be very unlikely to spend €800,000,000 on the infrastructure to support those sales. Clearly they’re confident, and I think they’re right to be. Glo will suit a lot of smokers who just didn’t get on with iQOS. Personally I think iQOS comes closer to the taste and sensation of a cigarette, but that has to be balanced against Glo’s huge battery capacity. Both devices have their strong points and I think Glo is going to do well as it hits new markets.

I’m not the only one who thinks that, either. The Times made BAT last week’s Share of the Week, citing the company’s investment in reduced harm products as a likely source of future growth. PMI might have seen their profit growth slow along with iQOS sales in Japan, but investors can obviously see a big market waiting to be tapped into.

Meanwhile, BAT’s Ploiești factory is going to get an extra 7,000 square metres of manufacturing space and plans to take on an extra 200 people to work on the new production line. PMI are also expanding in Romania, spending over $500 million to convert a cigarette factory near Bucharest into a HEET factory. I don’t expect these to be the last HnB projects launched in Europe.

Posted on

Heat not Burn news roundup – May 2018

heat not burn news

As you’ve probably guessed, the team at Heat not Burn UK take a keen interest in anything related to heated tobacco products, so we’re always watching the news to see if anyone’s saying anything we think you should know about. Sometimes we find a big story, and we’ll always let you know about that right away. Other times we just feel like giving you an update on what’s happening.

This week we couldn’t find any big stories to tell you about, so we’ve put together a few of the more interesting smaller ones. We think this is a good way to stay up to date on what’s happening, as well as warning of any threats that might be approaching. We can take it for granted that there will be threats; any vaper knows how vindictive the tobacco control industry can be. This week we’ve picked up one story about health warnings on HnB products, for example.

It’s not all bad news though. There’s some more good news in New Zealand’s bizarre iQOS court case, plus a study from Russia that looks very positive on the health front. Interesting times certainly lie ahead for HnB, but right now we’re feeling pretty optimistic about it all.

 

New Zealand gives up on Heet ban

One of the most positive HnB stories in April was the defeat of the New Zealand health ministry’s legal bid to ban Heets. Last May the ministry, for some bizarre reason, launched a court case against Philip Morris; their argument was that Heets fell under New Zealand’s ban on chewing tobacco, although they’re not actually supposed to be chewed.

It’s not clear why the ministry decided to do this; the case was brought under a 1990 law banning any tobacco product “described as suitable for chewing or any oral use other than smoking”. The law was specifically aimed at chewing tobacco, which carries a risk of oral cancer and sparked a series of health scares in the late 1980s and early 90s; no product like Heets was on the market at the time. However, the ministry came up with an eccentric interpretation of the law that would have banned Heets.

Luckily, Wellington District Court disagreed and threw the case out. They weren’t subtle about it either – the court basically told the ministry that what they were doing was the opposite of what the law was supposed to achieve. Of course, the ministry still had the option of appealing to a higher court.

This week’s good news is that they’ve decided not to do that. It seems that they’ve realised just how weak their legal position was, and backed down rather than face another defeat. This means Heets will stay legal in New Zealand, which is good news for the country’s smokers.

 

South Korea does something silly

South Korea has played a big part in the growth of HnB – after Japan, it’s one of the countries that has adopted the technology most enthusiastically, and BAT chose it as an early test market for their Glo. There’s also at least one indigenous Korean product, KT&G’s Lil /which we’re trying to get a hold of for a review). So at first glance it’s all looking pretty positive – but there seem to be political problems on the horizon.

Seoul’s Ministry of Health and Welfare has just announced that, from now on, HnB products will have to carry graphic health warnings in the packaging. These are the gory pictures that many countries already require on cigarette packets; now South Korea wants them on reduced-harm products too.

In fact graphic warnings were already required in South Korea, but some activists have complained that the image – a needle, representing drug addiction – was unclear. The new ones will show tumours. The ministry’s aim, unfortunately is to spread the message that HnB isn’t safer than smoking – despite all the evidence showing that it is.

 

PMI credits iQOS for growth

Philip Morris International announced a 9,4% revenue growth for 2017, and said this was down to demand for their iQOS device and the Heets it uses. According to CEO André Calantzopoulos the company’s HnB sales are projected to double in 2018. This is a positive sign for PMI’s ambition to establish itself as a leader in HnB, and gain an advantage over its competitors.

There are no guarantees,, though, and PMI shares fell by 17.5% in April following disappointing iQOS sales figures. Some people have interpreted this as a sign that the HnB bubble is already deflating: others aren’t so sure. So far Japan has accounted for the bulk of iQOS sales, and it’s possible that market is saturated for now – most of the smokers who want to switch could already have done so. If that’s the case there’s still a lot of potential for iQOS to sell well in other countries.

 

Science stacks up

HnB hasn’t been studied anywhere near as much as either vaping or smoking, but evidence of its safety is starting to build up. Anti-nicotine activists attacked the first studies because, although they were carried out by independent labs, they were funded by tobacco companies – a classic case of playing the man, not the ball. However, now there’s a new study that can’t be dismissed so easily.

Many governments are interested in the health risks of new tobacco products, and Russia is no exception. A few months ago Moscow seems to have asked a group of researchers to investigate, and their paper was released on the 7th of May. The results make encouraging reading.

The Russian team, from Kazan University, tested the urine of smokers, HnB users and never-smokers. What they found was that, in every case, levels of various toxins in the HnB users were comparable to what they found in the non-smokers – and much lower than in smokers. At the same time they found similar nicotine levels between HnB users and smokers. This backs up the existing evidence that HnB is an effective way of using nicotine that also eliminates most of the risks of smoking.

Posted on

Glo safety update – good news on DNA trials

DNA trials

Anti-nicotine zealots chose safety as their main battleground on e-cigarettes, and it didn’t work out too well for them. Now they seem to be doing the same again with Heat not Burn. Will it be more effective this time? Probably not.

We’ve already seen a lot of research from PMI on the safety of their iQOS device. Now British American Tobacco have released their own work on Glo, which is currently on sale in Japan and South Korea. Glo works on the same concept as iQOS, delivering vapour from heated tobacco that’s held in a cigarette-like stick, and the only real difference in the technology is that Glo heats its sticks to a lower temperature. That means we wouldn’t expect to see a huge difference in its vapour compared to iQOS – and, sure enough, we don’t.

Science and smoking

What BAT were interested in was the potential of Glo vapour to cause DNA changes in human cells. Damage to DNA can kill a cell – but, even worse, it can also cause cancer by making the cell grow and divide abnormally. Smoking is known to cause damage to thousands of genes; the question is, how does Glo compare?

Recently there’s been a lot of criticism of studies that use human cell cultures to measure the effects of e-cigarette vapour. This criticism is well aimed, because while the cells might be the same as the ones in a real human body, they don’t benefit from all the body’s layers of defence systems and repair capabilities. In a living body, damaged cells are quickly repaired or ejected; this doesn’t happen in a petri dish.

For their own trials BAT decided they could do better than that. Instead of a simple culture they used an actual simulation of a human airway. Known as MucilAir, it’s grown in a laboratory from cloned human cells and it replicates the body’s own defence mechanisms. The culture can produce mucus, to clear away contamination, and is covered in hair-like cilia like the ones human airways use to expel dust and particulates.

With the experimental tissues set up, BAT’s scientists then programmed a smoking machine to mimic the way people actually use Glo. This is another frequent problem with research into reduced-risk tobacco products – researchers set up their equipment to work in unrealistic ways. Several studies on e-cigs have turned out worthless because the machinery took puffs that were too long and too close together, producing dry hits and high levels of toxic substances that no real vaper would ever experience.

To carry out the actual experiment the machine produced vapour from the Glo and exposed the cells to it continuously for one hour; as a control, a second sample was exposed to smoke from a standard cigarette. Then, 24 hours after the experiment, cells were harvested and broken down to extract their DNA; which was then examined for changes. The process was repeated after another 24 hours to check for damage that took longer to show up. Then the results for Glo were compared with those for the cigarette.

Does Glo cause cancer?

The difference was dramatic. After 24 hours cigarette smoke had caused observable changes in 2,206 genes; Glo vapour had affected one. By 48 hours 2,727 genes were showing a reaction to the smoke, while all genes from the Glo sample were normal. After the researchers adjusted the figures to get a worst-case scenario Glo was still only affecting two genes, while smoke affected 2.809.

It’s obvious from this that Glo’s heated tobacco vapour has much less effect on DNA than cigarette smoke does – in fact, it would be interesting to see a comparison between Glo vapour and city air. So why are BAT insisting that “these results do not necessarily mean this product is less harmful than other tobacco products”? The reality is that’s exactly what these results mean, but heat not burn is in a complicated legal position just now. Philip Morris are still hoping their iQOS will be classed as a reduced risk product by the US FDA, which would allow them to advertise it as less harmful; Glo hasn’t reached that stage yet. Until it does we can expect BAT to be very cautious about what they say, to avoid any damaging legal challenges.

The reality, however, is that this is great news for heat not burn. The gene changes caused by cigarette smoke are known to be linked to lung cancer, as well as fibrosis and inflammation of lung tissue. The new research – which has been peer reviewed, and will be published in the medical journal Scientific Reports – shows that Glo is not causing these changes.

While the health effects of cigarettes are complicated, some things are quite simple. If Glo isn’t causing the gene changes that lead to cancer, it’s not going to give you that type of cancer. That doesn’t mean there are no health risks at all – we can’t say that about anything – but what we can say is that many of the ways cigarettes cause cancer just aren’t possible with Glo.

Earlier research into Glo shows that levels of toxic substances in the vapour are between 90% and 95% lower than in cigarette smoke. That fits together well with the new study. There isn’t a simple relationship between levels of a chemical and the effects it has. Some people make wild claims, such as “There’s no safe level of cigarette smoke!”, but the truth is there’s a safe level of anything. There’s a safe level for things like cyanide and arsenic. It might be a very low safe level, but it exists.

We’re probably fine

My guess – and it is a guess, but a reasonably informed one – is that the level of toxic chemicals in Glo vapour is low enough that it’s below the threshold where it’s going to do any harm. It seems reasonable to believe, based on the evidence we have so far, that using Glo or a similar product is going to eliminate most of the risks of smoking. Common sense backs this up; it isn’t nicotine or even tobacco that kills smokers – it’s smoke. Glo isn’t producing any smoke, so it’s sensible to assume we’re not going to see the same problems.

The last thing to say about this research is that it’s going to be attacked because of who carried it out. We’ve seen that already with research on iQOS, just because PMI paid for it – they didn’t even do the work themselves. BAT have tested Glo in their own labs, but they’ve handed over the data for peer review and it’s been approved of by experts. That won’t stop people attacking it, but they’ll attack the source because they can’t attack the data itself. So far the science is looking good for heated tobacco products, and that’s what counts.

Selling iQOS and HEETS

Posted on

Heat not Burn in 2017 – A pretty good year!

So we’re into the last month of 2017 and the end of the year is approaching fast. Christmas is three weeks away, and it’s likely quite a few smokers will be finding an iQOS starter kit under the tree as friends and family try to nudge them in a safer direction. Well, it might be a few smokers – or it might be a lot of smokers. Because 2017 has been a big year for Heat not Burn.

A lot has changed in the reduced-harm tobacco market since January. We’ve seen new products appear, and existing ones rolled out to wider audiences. HnB has started to attract attention from health researchers and lawmakers – which isn’t always a good thing, of course, but it’s an inevitable part of getting the products on sale. So, as Christmas decorations go up and the snow comes down, let’s have a look back at what 2017 has meant for Heat not Burn.

iQOS goes global

When iQOS was first released it was only available in a few test markets, but towards the end of 2016 it began appearing more widely. The UK’s first iQOS store opened in December 2016, and there are now three in London. Last year the product was almost unheard of, but now it’s becoming much better known.

The big challenge for iQOS is the US market. Before it can go on sale it has to be licensed by the Food and Drug Administration, and in March Philip Morris submitted the paperwork to have iQOS classed as a “Modified Risk Tobacco Product”. That application hasn’t been approved yet, but hopefully it should be decided next year. If the FDA approve it – and it’s hard to see how they can refuse – expect iQOS to be a big hit among US smokers.

UPDATE (Feb 2018) It was refused.

Meanwhile, the statistics coming out of Japan show just how much potential iQOS has. PMI say they can’t keep up with demand, and every new batch they deliver sells out right away. iQOS really seems to have made an impression – and cigarette sales in Japan fell by an astonishing 11% in the first six months of this year, as smokers moved to HnB.

The growth of Glo

So far iQOS doesn’t have any serious rivals as a mainstream HnB product, but that’s likely to change soon. BAT’s competing Glo was launched in Japan last year; now the market testing has been expanded to South Korea, and next year we can expect it to start hitting other countries. The UK is a likely candidate, thanks to a generally positive attitude to reduced-risk products; BAT will also want to build a presence before iQOS becomes too firmly established as the market leader.

Glo is also the product we have most hands-on experience with at Heat not Burn UK – we did the first UK review of the product a few months ago, following a sneak preview back in February when Dick Puddlecote managed to get his hands on one. That experience was pretty convincing – Glo has a lot of potential, and we think smokers are going to like it when it hits the UK shelves.

Heat not Burn UK visits PMI

In April we were offered the chance to send someone to PMI’s research facility at The Cube in Neuchatel, Switzerland, to see what progress is being made on HnB. This gave us a chance to look at the latest science on the safety of iQOS, which is very encouraging, as well as seeing how HEETs are made in the Neuchatel factory.

What really encouraged us is that PMI aren’t just pinning all their hopes on a single product. They know that electronic devices like iQOS (or e-cigarettes) don’t work for everyone – they’re not a lot of use for people who spend long periods working outdoors or at sea, for example – so they’re working on four separate non-cigarette devices. These include a charcoal-heated cigarette and a device that creates nicotine vapour through a chemical reaction, as well as iQOS and the Mesh e-cigarette.

Lil joins the race

South Korea is a popular test market for HnB products, with iQOS and Glo both going on sale there early in their careers. Now the country’s own industries are waking up to the possibilities. Korean Tobacco & Ginseng have developed their own device, the Lil, which also heats tobacco sticks to create a vapour.

Lil is on limited release in South Korea just now, but should be rolled out across the country quite soon. The question is whether KT&G plan to market it globally. So far they haven’t announced any plans, but H&B isn’t a crowded market right now. This would be a huge opportunity for them to build a global presence.

We’ve contacted KT&G to ask if we can have a Lil for review, but haven’t heard back from them yet. Hopefully we’ll have some news on that soon, because it’s an interesting-looking device and we think it deserves a wide audience.

Looking forward

So this has been an exciting year for Heat not Burn; the technology is making its way into the mainstream, hundreds of millions of people around the world are able to buy the products, and that number is set to grow fast in 2018. If what we’ve seen from Japan is any guide, there’s a possibility that HnB could overtake e-cigarettes as the favourite alternative to smoking within a few years.

In any case, 2017 isn’t quite over yet. There are still a few weeks to go before New Year, and the team at Heat not Burn UK won’t be taking that time off. There will be a video review for the Vapour 2 Pro we’ve been testing for the last month, and we also have a new toy to play with – the PAX 3. This is the latest upgrade of the PAX 2, the most respected loose-leaf vaporiser on the market, and there’s one sitting on the table in HnB UK’s secret headquarters. That will be getting unboxed soon, and tested over the next couple of weeks, so drop in to see what we think of it!

Posted on

Will heat not Burn make Britain smoke free?

Smoke Free

Ever since the first Heat not Burn devices appeared, they’ve been controversial. Most of that controversy has come from politicians and the public health industry, who seem to have hated the technology right from the beginning. If you’re a vaper their complaints will be pretty familiar; HnB users haven’t really quit, they’re still addicted to nicotine, it’s just a different kind of cigarette, it’s all a Big Tobacco plot to get children hooked… you know the sort of thing. It’s all hyped up, it’s all alarmist – and it’s all untrue.

What is true? It’s true that Heat not Burn has the potential to make smoking go away. Public health say they want this to happen, but over the past few years they’ve been very hostile to any new alternatives to smoking. The cynical might think they’re more worried about protecting their jobs than helping smokers find safer alternatives.

This might explain why all the targets set by the traditional anti-smoking lobby are slightly unambitious. Currently the British government’s tobacco control plan – largely written by taxpayer-funded activists like ASH – aims to create a “smoke free generation” by reducing the smoking rate to 5% (it’s currently around 16%). Obviously a 5% smoking rate isn’t “smoke free” in any way that resembles reality, because 5% of the UK population is actually quite a lot of people, but that’s their target. According to the trend in smoking rates over the last few years, that target should be achieved around 2040.

Now that figure is being challenged from an unexpected source. A couple of weeks ago Philip Morris released a report produced for them by Frontier Economics, an analysis consultant. Frontier have looked at the data on smoking rates in the UK, examined the current trends and what’s driving them, and come to an interesting conclusion.

The government might think that they can achieve their 5% target by 2040, but Frontier and PMI are saying that, in fact, they could get there much sooner – by 2029, just twelve years from now. It might seem surprising to hear a tobacco company advocating a faster decline in smoking, but in fact PMI have been saying this for a while now. When I visited their research centre at the Cube back in April they were very open about the fact that they plan to move away from cigarettes as fast as possible, and that the future is in alternative products.

What about vaping?

The problem is that, right now, the most common alternative product in the UK is e-cigarettes – and it looks like they might be running out of steam. The number of vapers in Britain is still rising, and an ever-increasing percentage of them have switched away from cigarettes completely (just under half of UK vapers also smoke, down from 70% two years ago), but growth is slowing down. In 2014, 800,000 British smokers started vaping, but it’s likely that by the end of 2017 the year’s total will be just 100,000. The most likely reason for this fall is that smokers have been scared off by false claims about health risks.

Now PMI say that it’s possible to reach the “Smokefree” target eleven years early – but only if the number of smokers switching to safer alternatives starts to accelerate again, back to where it was in 2014. The question is, what alternative should they switch to?

E-cigarettes are still a popular option – according to Public Health England they’re now the UK’s top choice among smokers who want to quit. It’s possible that, if people like ASH stop talking nonsense about them, the number of smokers switching to them every year could rise again. On the other hand, it’s also possible they could be overtaken by Heat not Burn. In fact I think that’s very likely.

When it comes to quitting smoking, e-cigs have been a game changer. The number of smokers in Britain is falling faster than it ever has before, even though fewer people are buying nicotine gum or using NHS quit services. They’re not ideal for everyone, though. Some smokers find them too complicated; others just want something that tastes like their favourite cigarette.

Is Heat not Burn the future?

I think a lot of smokers who aren’t interested in e-cigs are going to be very interested in HnB, for a couple of reasons. Firstly, a device like iQOS isn’t as simple as a cigarette – what is? – but it’s a lot less complicated than a high-end e-cig. Secondly, HnB can recreate the taste of cigarette smoke almost perfectly and that’s important to a lot of people. Many vapers love the array of new flavours they can use, but there are also plenty smokers who just want something that tastes like the smoke they’re used to. E-cigs are never going to recreate that flavour – they just don’t work that way – but PMI have spent a lot of money making sure iQOS tastes as much like a Marlboro as possible, and it’s paid off.

If you want to see how well it’s paid off, just look at Japan. iQOS launched there three years ago, and as of last month it’s taken 13.3% of the country’s nicotine market. It’s already broken even, paying for the enormous cost of developing it, and it isn’t even on sale in most countries yet. E-cigs have been growing fast, but not that fast.

It doesn’t stop with iQOS, either. As well as its direct competitors, like Glo and the new Lil from KT&G, there are more products due on the market soon. A couple of paragraphs back I asked what’s as simple as a cigarette. Well, PMI’s next product is. Using the same concept as RJ Reynold’s Revo, but apparently working much better, these are exactly as easy to use a cigarette. Just take it out the pack, light the end – which contains a charcoal heating pellet – then, when you’re finished it, stub it out in an ashtray. If it works as well as PMI are hoping, this could be even bigger than iQOS.

There’s a lot going on in the world of HnB right now, with new products appearing and existing ones being rolled out into new markets. There’s also a lot of opposition from the usual suspects in tobacco control, and that has the potential to put smokers off trying HnB for themselves. If we’re lucky, however, smoking could more or less disappear from the UK before 2030, and it won’t be plain packs or nagging health campaigns that do it; it will be e-cigs and heated tobacco products.

Posted on

KT&G Enter The Heat Not Burn Market With The Lil

Korea Tobacco & Ginseng Corporation, better known as KT&G, are the leading tobacco company in South Korea. It looks like they have seen the light with regards to tobacco harm reduction, because they’ve just launched their very own heat not burn product – the Lil.

The product is more similar in design to the BAT Glo than it is to the PMI iQOS, and it looks like it operates exactly the same way that Glo does; it heats the tobacco stick externally, rather than having a central heated blade like PMI’s iQos does. The tobacco stick that Lil uses will be called Fiit. It will also be interesting to see if KT&G run into any patent issues in the future from either PMI or BAT, due to the nature of the tobacco sticks.

The device itself will be available in two finishes –  Creamy White and Saffron Blue. KT&G are saying that the unit holds enough charge for 20 Fiits to be used without the need for charging. In the past we’d have been sceptical of a claim like that, but when we reviewed the BAT Glo we found that it did indeed hold enough charge for 20 uses with a fair amount of charge remaining. As the unit is almost the same size as Glo we expect that the Lil’s battery will also be as good as Glo’s is.

Lil is currently on a very limited release in South Korea, but it’s set to gradually roll out to the whole of South Korea.

Will KT&G release it worldwide? That’s a tough one to call, but we doubt that it will. It may well end up in the Asian market but we doubt that it will go as far as Europe or the USA. We would love to be proved wrong though!

As for cost, the Lil has been released at a price that’s similar to Glo and a bit cheaper than iQOS. The Fiit tobacco-filled sticks are going to be priced similar to the Heets and NeoStiks used by its competitors. There is currently a very real possibility of a tax hike going through the South Korean National assembly; that would ramp up the tax on a packet of Fiits, punishing people for having the temerity to switch to a less harmful option –  and, of course, keeping those tobacco taxes rolling in.

Heat Not Burn UK will be trying to get our hands on a Lil so that we can give it a full going over in the near future for one of our extensive reviews. Also if we can get our hands on enough of them we will be selling them right here on this website along with PMI’s iQOS that we are already selling in large numbers.

UPDATE (13th Nov 17) As expected Korea’s national assembly have decided to tax heat not burn products to the same level as regular combustible cigarettes, thereby punishing people for choosing to use a safer alternative to traditional smoking. There’s not a lot else to add other than saying this is an incredibly moronic decision and will do nothing to help reduce South Korea’s smoking prevalence which currently stands at 19.9%. Expect the price of HEETS etc. to rise from next month in South Korea.

UPDATE (11th Dec 17)

According to a new report from Korea Joongang Daily pretty soon there will be a chance that Heat Not Burn refills will cost MORE than conventional cigarettes in South Korea. How on earth can reduced risk products be priced higher than regular cigarettes? How is this going to help reduce the high smoking rate in South Korea? We have a feeling that there’s something dodgy going on here.

 

 

Posted on

More Heat not Burn science – Glo has been tested!

Back in April we looked at the latest research on the safety of iQOS compared to traditional cigarettes, and it looked very encouraging for heat not burn devices. Studies carried out for PMI by independent labs found that the vapour from an iQOS had much lower levels of toxic chemicals than cigarette smoke – in most cases, 90% or 95% lower. That’s impressive, especially considering that the tests looked at a much larger range of chemicals than any research done by public health groups.

The down side to this research was that it only looked at iQOS. Yes, that particular product is much safer than smoking, but does it apply to HnB in general? Realistically it’s going to be a while before we know that for sure, but this week some more results were released, this time by British American Tobacco. We recently did the first full UK review of BAT’s new Glo, their entry in the HnB market; now there’s some science to go with our impressions of this device.

Real science?

Although research done by the tobacco industry in the past has had a bad reputation, things have moved on a long way since the 1960s. Companies like BAT know that anything they publish is going to be scrutinised in minute detail by activist scientists looking for the slightest hint of foul play, so they don’t take any chances. These days they’re scrupulous about following good research procedures and releasing details of their methods, so the research can be studied and replicated. How well are they doing at that? Well, all the criticism of PMI’s research on iQOS has been about where the money comes from; nobody has said a word against the science. That probably tells us all we need to know.

BAT seem to have been just as careful with their own research, which makes the results worth looking at. For a start, they didn’t just bodge up some shonky equipment, like one university did recently when they used syringes to collect vapour from e-cigs. Instead, they studied how people actually use Glo then programmed a robot smoking device to replicate that. Then they tested Glo, collecting the vapour for comparison with a range of other products.

In total seven products were tested:

  • Glo
  • Three conventional cigarettes, including the standard 3R4F reference cigarette used in most smoking research.
  • “Another THP (tobacco-heating product)”, almost certainly an iQOS.
  • “A hybrid product”, BAT’s iFuse
  • An e-cigarette.

This is a good selection of products, covering all the main categories on the market right now. BAT also tested for a wide range of chemicals. They used the Health Canada testing method to collect vapour, because it’s one of the most thorough methods in use, combined with their own list of chemicals. The FDA test for 28 different toxins in cigarette smoke; the International Agency for Research on Cancer only measure fifteen. BAT’s list has 44 substances in it – not quite as extensive as the 58 that PMI look for, but still much more impressive than what most health researchers are doing.

Checking the chemistry

What’s really impressive is the results of all this testing. Unsurprisingly, most of the vapour from Glo consisted of water vapour and glycerine, which is added to increase the vapour output. That’s interesting, because when we looked at the innards of a NeoStik the tobacco in it looked much less processed than the contents of a Heet. Obviously, even though what the Glo is heating looks like normal cigarette tobacco, BAT have added a considerable amount of glycerine to it somehow. That doesn’t cause any worries, though; glycerine is perfectly safe to inhale.

The nicotine content of the vapour was about 62% of that found in cigarette smoke. This makes sense; using the Glo, it felt similar to a light cigarette, while the 3R4F cigarette is a full-strength blend. In any case, this sort of nicotine dose is close enough to a cigarette that it’s an effective replacement.

Moving on to the less welcome substances, the tests showed sharp reductions in all of them. The lowest reductions were for mercury, at 57.1%, followed by ammonia at 64.3%. Neither of these chemicals are at high enough levels in cigarette smoke to be much of a worry anyway, but any reduction is welcome. For the other 41 chemicals tested, 39 had a reduction of at least 80% and 36 saw levels reduced by 90% or more. Almost half had at least a 99% reduction. The total reduction in toxins was around 90%.

Does this mean it’s safe?

It’s worth pointing out that a 90% reduction in toxins is impressive, but it doesn’t tell the whole story. For example, the single most harmful chemical in cigarette smoke is carbon monoxide, and smoke contains a lot of it. The level in Glo vapour was 98.6% lower. Benzene is another major problem for smokers; Glo reduces the leve by 99.3%. Hydrogen cyanide – 98.8% lower. What this means is that while switching from cigarettes to Glo cuts total toxins by 90%, it almost certainly cuts the health risk by a lot more.

More good news from the study is that iQOS and the e-cigarette gave roughly similar results to Glo (although many of the toxins aren’t found in e-cig vapour at all).

Between this new research and what PMI have already released about iQOS, it seems obvious that HnB is much safer than smoking, and probably about the same as vaping an e-cigarette. A reduction in risk of at least 95% seems likely to be about right. Does this mean that switching to Glo cuts your risk of premature death by 95%? No – it almost certainly cuts it by a lot more than that. Jumping from a ground-floor window is about 95% less risky than jumping from a fourth-floor one, but the risk that’s left doesn’t mean your chance of dying drops from 50% to “only” 2.5%. It means that, if you’re really unlucky, you might twist your ankle.

If you need a final vote of confidence in BAT’s new research it’s just been published in a peer-reviewed medical journal, Regulatory Toxicology and Pharmacology. Peer review means a panel of experts have examined and decided that the experiments were good science and the data has been properly interpreted. Of course some extremists will refuse to accept it simply because it was funded by BAT, but open-minded people like our readers can find it here.

Posted on

BAT Glo- Heat Not Burn UK gets hands on.

BAT Glo

As mentioned before we are not all about the iQOS, sure it’s a great bit of kit but there are also many others out there. Here we see our very own HnB aficionado Fergus doing a hands on video review of British American Tobacco’s entry into the heat not burn market, the BAT Glo.

As Fergus rightly points out this is currently on limited release but as soon as it becomes available here in the UK we will do our best to add it to our online web store where we are currently selling the iQOS.

Some of the team here have been trying their best to shed some new ight on when the BAT Glo is expected to be released here in the UK but so far BAT are playing their cards very close to their chests and we have no further info to share with you.

Also please see the “related” area underneath this video review for more posts related to the BAT Glo, including a very good tear down of the NeoStick, which is the name that BAT uses for its tobacco sticks.

We will be doing another video on the Vapour2 PRO Series 7 within the next couple of weeks along with an extensive blog post review so watch this space!

Update: As promised here is an extensive blog review of the Vapour 2 Pro 7